モノメチルアウリスタチンE
↑ A study of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies
↑ Coleman, Robert L; Lorusso, Domenica; Gennigens, Christine; González-Martín, Antonio; Randall, Leslie; Cibula, David; Lund, Bente; Woelber, Linn et al. (May 2021). “Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study” (英語). The Lancet Oncology 22 (5): 609–619. doi:10.1016/S1470-2045(21)00056-5. https://linkinghub.elsevier.com/retrieve/pii/S1470204521000565.
↑ Indusatumab vedotin (MLN-0264) Clinical Trials. March 2015